BioNTech SE: CEO Sahin Ugur sold 24,000 shares

What happened Sahin Ugur, CEO, sold 24,000 ordinary shares in an open-market or private sale at $95.86 per share on Oct 7, 2026, for $2,300,633.

Key details

• Transaction date and price: Oct 7, 2026, sale at $95.86 per share (transaction code S).
• Shares owned after the transaction: not reported on this filing.
• Footnotes: the ordinary shares are held by Medine GmbH; the reporting person is the sole shareholder of Medine GmbH. The filing states 106,721 ordinary shares noted are held for the benefit of an individual under a trust arrangement, where Medine GmbH exercises voting power but not dispositive power over those shares. The reporting person may be deemed to beneficially own the shares held by Medine GmbH.
• Plan/remark: the sales were effected pursuant to a Rule 10b5-1 trading plan established by the reporting person on Jun 3, 2026.
• Filing date: Oct 7, 2026; no late filing is indicated in the report.

Why it may matter

• The sale was executed under a Rule 10b5-1 plan, per the filing. A filing does not show why the insider traded or why the company acted.